Faculty Disclosures
Grace L Chua, MD
Research support from, speaking honoraria, and/or acting as an advisor to CPD Network Association, Canadian Medical and Surgical Knowledge Translation Research Group, Canadian Collaborative Research Network, Canadian Cardiovascular Society, Canadian Heart Failure Society, Canadian Society of Endocrinology, Canadian Society of Nephrology, Catalytic Health, CHEP PLUS, COPD Canada, Diabetes Care Community, EOCI Pharmacomm, HealthSpanRx, LiV Medical Agency, Meducom Health Inc, Medscape, My Weight What to Know, Partners in Progressive Medical Education, Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim-Eli Lilly Alliance, Bristol Myers Squibb, Eli-Lilly, HLS Therapeutics, Novartis, Novo Nordisk, Pfizer, GSK, Servier.
Kim A Connelly, MBBS, PhD
Research support from, speaking honoraria, and/or acting as an advisor to Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novartis, Novo Nordisk, Sanofi, Servier, CHRC, and GSK.
Anique Ducharme, MD
Grants and/or research support and/or speaking honoraria from CHFS, CCS, Abbott, Alnylam, Astra-Zeneca, Bayer, Boehringer-Ingelheim, BridgeBio, CSL Behring Canada, GlaxoSmithKline, Lilly, Merck, Novartis, NovoNordisk, and Pfizer.
Jonathan G Howlett, MD
Research support from and/or acting as an advisor to Bayer Canada, Novo Nordisk, Viatris Canada, BI Lilly, Boehringer Ingelheim Canada, Abbott, AstraZeneca, and Amgen.
Lawrence A Leiter, MD
Research support from, speaking honoraria, and/or acting as an advisor to Abbott, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, GSK, HLS Therapeutics, Merck, Novartis, Novo Nordisk, and Regeneron as well as a member of a DSMB for CRISPR Therapeutics and vTv Therapeutics.
G B John Mancini, MD
Research support from, speaking honoraria, and/or acting as an advisor to Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, GSK, HLS Therapeutics, Merck, Novartis, Novo Nordisk, Esperion and Ultragenyx.
Paul M Ridker, MD
Received institutional research grant support from Kowa, Novartis, Amarin, Pfizer, Esperion, Novo Nordisk, NHLBI, and the NCI; during the past 3 years has served as a consultant to Novartis, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSL Behring, Janssen, Civi Biopharm, Glaxo Smith Kline, SOCAR, Novo Nordisk, Eli Lilly, New Amsterdam, Boehringer-Ingelheim, Cytokinetics, Nodthera, Tourmaline Bio and Cardio Therapeutics; has minority shareholder equity positions in Uppton, Bitteroot Bio, and Angiowave; and receives compensation for service from the Leducq Foundation, Paris FR.
Roopinder K Sandhu, MD, MPH
No disclosures
Tara L Sedlak, MD, MBA
Speaking honoraria, and/or acting as an advisor to Amgen, Novo Nordisk, Bayer, BI Lilly, KYE Pharmaceuticals, Novartis, HLS, Pendopharm, Pfizer, CCRN, and CPD Network.
Hwee Teoh, PhD
Personal fees from the Canadian Medical and Surgical Knowledge Translation Research Group and LMC Healthcare.
Subodh Verma, MD, PhD
Grants and/or research support and/or speaking honoraria from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Canadian Heart Research Centre, Canadian Medical and Surgical Knowledge Translation Research Group, Eli Lilly, HLS Therapeutics, Humber River Health, Janssen, Merck, Novartis, Novo Nordisk, Pfizer, PhaseBio, S & L Solutions Event Management Inc, Sanofi, and Sun Pharma.
Copyright© | MYConference Suite Registration | D.E. Systems | All Right Reserved.